Safety and Efficacy of Low Temperature Contrast in UAP Patients During PCI (LOTA-I)

NACompletedINTERVENTIONAL
Enrollment

440

Participants

Timeline

Start Date

August 1, 2018

Primary Completion Date

July 1, 2023

Study Completion Date

July 1, 2023

Conditions
Unstable Angina Pectoris
Interventions
OTHER

low temperature contrast

UAP patients undergoing PCI were performed with low temperature contrast. The investigators used thermal insulation equipment to keep contrast at 5℃. The EKG and blood pressure were monitored during the PCI procedure. After PCI, the investigators monitored levels of myocardial injury biomarkers for 3 days every 8 hours.

Trial Locations (7)

210006

Nanjing First Hospital, Nanjing

213000

The First People's Hospital of Changzhou, Changzhou

214200

The People's hospital of Yixing, Yixing

221006

The Affiliated Hospital of Xuzhou Medical University, Xuzhou

222061

The First People's Hospital of Lianyungang, Lianyungang

239000

The First People's Hospital of Chuzhou, Chuzhou

239400

MingGuang People's Hospital, Chuzhou

All Listed Sponsors
lead

Nanjing First Hospital, Nanjing Medical University

OTHER

NCT03700567 - Safety and Efficacy of Low Temperature Contrast in UAP Patients During PCI (LOTA-I) | Biotech Hunter | Biotech Hunter